Tuesday, November 15, 2016

BRIEF-Janssen's Guselkumab shows promise in psoriatic arthritis treatment in Phase 2 trial

* Janssen - two serious AES were reported in study including

one knee injury and one myocardial infarction

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)